drug_type
RELEVANT_DRUG
intervention_type
Drug
drug_description
An investigational antibody–drug conjugate (ADC) in which a monoclonal antibody targeting an undisclosed tumor-associated antigen is linked to a cytotoxic payload; after antigen binding and internalization, the payload is released intracellularly to kill tumor cells.
nci_thesaurus_definition
NCI thesaurus definition not available.
drug_category
ANTIBODY DRUG CONJUGATE
drug_class
Conjugate
drug_delivery_route
Intravenous
drug_mechanism_of_action
Monoclonal antibody binds an undisclosed tumor-associated surface antigen, is internalized, and a cleavable linker releases a cytotoxic payload inside the cancer cell, resulting in intracellular cytotoxicity (e.g., DNA damage or microtubule disruption) and tumor cell death.
drug_name
TORL-3-600
nct_id_drug_ref
NCT05948826